77 related articles for article (PubMed ID: 9584206)
1. Differential uncoupling of A1 adenosine and D2 dopamine receptors by suramin and didemethylated suramin (NF037).
Waldhoer M; Bofill-Cardona E; Milligan G; Freissmuth M; Nanoff C
Mol Pharmacol; 1998 May; 53(5):808-18. PubMed ID: 9584206
[TBL] [Abstract][Full Text] [Related]
2. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain.
Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of receptor/G protein coupling by suramin analogues.
Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M
Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
Wise A; Sheehan M; Rees S; Lee M; Milligan G
Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
[TBL] [Abstract][Full Text] [Related]
5. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
6. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
Boundy VA; Pacheco MA; Guan W; Molinoff PB
Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
[TBL] [Abstract][Full Text] [Related]
7. Suramin analogues as subtype-selective G protein inhibitors.
Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C
Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of recombinant bovine A1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition.
Figler RA; Graber SG; Lindorfer MA; Yasuda H; Linden J; Garrison JC
Mol Pharmacol; 1996 Dec; 50(6):1587-95. PubMed ID: 8967981
[TBL] [Abstract][Full Text] [Related]
9. Immunoprecipitation of A1 adenosine receptor-GTP-binding protein complexes in ciliary epithelial cells.
Wax MB; Patil RV
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3057-63. PubMed ID: 8206723
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
13. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
14. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors.
Lane JR; Powney B; Wise A; Rees S; Milligan G
J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829
[TBL] [Abstract][Full Text] [Related]
15. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
16. Reconstitution of bovine A1 adenosine receptors and G proteins in phospholipid vesicles: betagamma-subunit composition influences guanine nucleotide exchange and agonist binding.
Figler RA; Lindorfer MA; Graber SG; Garrison JC; Linden J
Biochemistry; 1997 Dec; 36(51):16288-99. PubMed ID: 9405064
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA
J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659
[TBL] [Abstract][Full Text] [Related]
18. Interactions between the dopamine D2 receptor and GTP-binding proteins.
Plug MJ; Möller W; Dijk J
Biochem Int; 1992 Oct; 28(1):21-9. PubMed ID: 1445393
[TBL] [Abstract][Full Text] [Related]
19. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits.
Chung WC; Kermode JC
J Pharmacol Exp Ther; 2005 Apr; 313(1):191-8. PubMed ID: 15626724
[TBL] [Abstract][Full Text] [Related]
20. Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution.
Munshi R; Linden J
Mol Pharmacol; 1990 Aug; 38(2):170-6. PubMed ID: 2117248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
